306 related articles for article (PubMed ID: 24733928)
1. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
3. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
4. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
Glynn SA; Boersma BJ; Dorsey TH; Yi M; Yfantis HG; Ridnour LA; Martin DN; Switzer CH; Hudson RS; Wink DA; Lee DH; Stephens RM; Ambs S
J Clin Invest; 2010 Nov; 120(11):3843-54. PubMed ID: 20978357
[TBL] [Abstract][Full Text] [Related]
5. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
Ambs S; Glynn SA
Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
[TBL] [Abstract][Full Text] [Related]
6. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
[TBL] [Abstract][Full Text] [Related]
7. NOS2 as an Emergent Player in Progression of Cancer.
Thomas DD; Wink DA
Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
[TBL] [Abstract][Full Text] [Related]
8. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors.
Mohan S; Patel S; Barlow D; Rojas AC
Adv Med Sci; 2020 Sep; 65(2):424-428. PubMed ID: 32919119
[TBL] [Abstract][Full Text] [Related]
9. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.
Switzer CH; Glynn SA; Cheng RY; Ridnour LA; Green JE; Ambs S; Wink DA
Mol Cancer Res; 2012 Sep; 10(9):1203-15. PubMed ID: 22878588
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER
Cheng RYS; Ridnour LA; Wink AL; Gonzalez AL; Femino EL; Rittscher H; Somasundaram V; Heinz WF; Coutinho L; Rangel MC; Edmondson EF; Butcher D; Kinders RJ; Li X; Wong STC; McVicar DW; Anderson SK; Pore M; Hewitt SM; Billiar TR; Glynn SA; Chang JC; Lockett SJ; Ambs S; Wink DA
Cell Death Dis; 2023 May; 14(5):319. PubMed ID: 37169743
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.
Ridnour LA; Barasch KM; Windhausen AN; Dorsey TH; Lizardo MM; Yfantis HG; Lee DH; Switzer CH; Cheng RY; Heinecke JL; Brueggemann E; Hines HB; Khanna C; Glynn SA; Ambs S; Wink DA
PLoS One; 2012; 7(9):e44081. PubMed ID: 22957045
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.
Cheng RY; Basudhar D; Ridnour LA; Heinecke JL; Kesarwala AH; Glynn S; Switzer CH; Ambs S; Miranda KM; Wink DA
Nitric Oxide; 2014 Dec; 43():17-28. PubMed ID: 25153034
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha.
Singh K; Balligand JL; Fischer TA; Smith TW; Kelly RA
J Biol Chem; 1996 Jan; 271(2):1111-7. PubMed ID: 8557638
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of the inducible nitric oxide synthase (NOS2) splicing variant S3 promotes autophagic cell death from nitrosative stress in SW480 human colon cancer cells.
Castro ED; Mathias PPM; Batista WL; Sato AYS; Toledo MS; de Almeida VT; Curcio MF; da Costa PE; Stern A; Monteiro HP
Cell Biol Int; 2022 Jan; 46(1):158-169. PubMed ID: 34719858
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
18. IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB.
Gao Q; Liu Y; Wu Y; Zhao Q; Wang L; Gao S; Wen W; Zhang W; Guo N; Zhou J; Yuan Z
Int J Mol Med; 2016 Feb; 37(2):347-58. PubMed ID: 26677135
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
Burke AJ; Garrido P; Johnson C; Sullivan FJ; Glynn SA
Antioxid Redox Signal; 2017 Jun; 26(18):1078-1090. PubMed ID: 28326819
[TBL] [Abstract][Full Text] [Related]
20. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]